Effectiveness and safety of first-generation protease inhibitors in clinical practice: Hepatitis C virus patients with advanced fibrosis

AIM: To evaluates the effectiveness and safety of the first generation, NS3/4A protease inhibitors (PIs) in clinical practice against chronic C virus, especially in patients with advanced fibrosis. METHODS: Prospective study and non-experimental analysis of a multicentre cohort of 38 Spanish hospita...

Full description

Saved in:
Bibliographic Details
Published in:World J Gastroenterol
Main Authors: Salmerón, Javier, Vinaixa, Carmen, Berenguer, Rubén, Pascasio, Juan Manuel, Sánchez Ruano, Juan José, Serra, Miguel Ángel, Gila, Ana, Diago, Moisés, Romero-Gómez, Manuel, Navarro, José María, Testillano, Milagros, Fernández, Conrado, Espinosa, Dolores, Carmona, Isabel, Pons, José Antonio, Jorquera, Francisco, Rodriguez, Francisco Javier, Pérez, Ramón, Montero, José Luis, Granados, Rafael, Fernández, Miguel, Martín, Ana Belén, Muñoz de Rueda, Paloma, Quiles, Rosa
Format: Artigo
Language:Inglês
Published: Baishideng Publishing Group Inc 2015
Subjects:
Prospective Study
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC4533049/
https://ncbi.nlm.nih.gov/pubmed/26290644
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v21.i30.9163
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items